Assyro AI

Orange Book product · Generic (ANDA)

CEFOTAXIME

CEFOTAXIME SODIUM

Generic (ANDA)ANDA 064201DISCN FRESENIUS KABI USA

At a glance

Mar 24, 2000

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 24, 2000

    26 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CEFOTAXIME SODIUM

Strength

EQ 10GM BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 064201

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CEFOTAXIME SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.